about
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbot...
Read More
4.06
0.15
(3.84%)
77,009
XNAS Volume
XNAS 14 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
BioAtla Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..